Impact of HIV-1 Diversity on Its Sensitivity to Neutralization

被引:20
作者
Stefic, Karl [1 ,2 ]
Bouvin-Pley, Melanie [1 ]
Braibant, Martine [1 ]
Barin, Francis [1 ,2 ]
机构
[1] Univ Tours, Inserm U1259, F-37000 Tours, France
[2] CHRU Tours, Ctr Natl Reference VIH, Lab Associe, F-37000 Tours, France
关键词
HIV-1; vaccine; broadly neutralizing antibodies; diversity; evolution; envelope; IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIBODY-RESPONSE; MONOCLONAL-ANTIBODIES; DISEASE PROGRESSION; GLYCOSYLATION SITES; ELITE NEUTRALIZER; HUMORAL IMMUNITY; ENVELOPE; VACCINE; INFECTION;
D O I
10.3390/vaccines7030074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The HIV-1 pandemic remains a major burden on global public health and a vaccine to prevent HIV-1 infection is highly desirable but has not yet been developed. Among the many roadblocks to achieve this goal, the high antigenic diversity of the HIV-1 envelope protein (Env) is one of the most important and challenging to overcome. The recent development of broadly neutralizing antibodies has considerably improved our knowledge on Env structure and its interplay with neutralizing antibodies. This review aims at highlighting how the genetic diversity of HIV-1 thwarts current, and possibly future, vaccine developments. We will focus on the impact of HIV-1 Env diversification on the sensitivity to neutralizing antibodies and the repercussions of this continuous process at a population level.
引用
收藏
页数:14
相关论文
共 108 条
[1]   Immune Correlate-Guided HIV Vaccine Design [J].
Alter, Galit ;
Barouch, Dan .
CELL HOST & MICROBE, 2018, 24 (01) :25-33
[2]   The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes [J].
Bai, Hongjun ;
Li, Yifan ;
Michael, Nelson L. ;
Robb, Merlin L. ;
Rolland, Morgane .
PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (06)
[3]   HIV-1 antibodies in prevention of transmission [J].
Barin, Francis ;
Braibant, Martine .
CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) :273-278
[4]  
Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/S0140-6736(18)31364-3, 10.1016/s0140-6736(18)31364-3]
[5]   Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys [J].
Barouch, Dan H. ;
Stephenson, Kathryn E. ;
Borducchi, Erica N. ;
Smith, Kaitlin ;
Stanley, Kelly ;
McNally, Anna G. ;
Liu, Jinyan ;
Abbink, Peter ;
Maxfield, Lori F. ;
Seaman, Michael S. ;
Dugast, Anne-Sophie ;
Alter, Galit ;
Ferguson, Melissa ;
Li, Wenjun ;
Earl, Patricia L. ;
Moss, Bernard ;
Giorgi, Elena E. ;
Szinger, James J. ;
Eller, Leigh Anne ;
Billings, Erik A. ;
Rao, Mangala ;
Tovanabutra, Sodsai ;
Sanders-Buell, Eric ;
Weijtens, Mo ;
Pau, Maria G. ;
Schuitemaker, Hanneke ;
Robb, Merlin L. ;
Kim, Jerome H. ;
Korber, Bette T. ;
Michael, Nelson L. .
CELL, 2013, 155 (03) :531-539
[6]  
Beretta M, 2018, AIDS, V32, P1917, DOI [10.1097/qad.0000000000001906, 10.1097/QAD.0000000000001906]
[7]   Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design [J].
Bonsignori, Mattia ;
Montefiori, David C. ;
Wu, Xueling ;
Chen, Xi ;
Hwang, Kwan-Ki ;
Tsao, Chun-Yen ;
Kozink, Daniel M. ;
Parks, Robert J. ;
Tomaras, Georgia D. ;
Crump, John A. ;
Kapiga, Saidi H. ;
Sam, Noel E. ;
Kwong, Peter D. ;
Kepler, Thomas B. ;
Liao, Hua-Xin ;
Mascola, John R. ;
Haynesa, Barton F. .
JOURNAL OF VIROLOGY, 2012, 86 (08) :4688-4692
[8]   Drift of the HIV-1 Envelope Glycoprotein gp120 toward Increased Neutralization Resistance over the Course of the Epidemic: a Comprehensive Study Using the Most Potent and Broadly Neutralizing Monoclonal Antibodies [J].
Bouvin-Pley, M. ;
Morgand, M. ;
Meyer, L. ;
Goujard, C. ;
Moreau, A. ;
Mouquet, H. ;
Nussenzweig, M. ;
Pace, C. ;
Ho, D. ;
Bjorkman, P. J. ;
Baty, D. ;
Chames, P. ;
Pancera, M. ;
Kwong, P. D. ;
Poignard, P. ;
Barin, F. ;
Braibant, M. .
JOURNAL OF VIROLOGY, 2014, 88 (23) :13910-13917
[9]   Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic [J].
Bouvin-Pley, Melanie ;
Beretta, Maxime ;
Moreau, Alain ;
Roch, Emmanuelle ;
Essat, Asma ;
Goujard, Cecile ;
Chaix, Marie-Laure ;
Moire, Nathalie ;
Martin, Loic ;
Meyer, Laurence ;
Barin, Francis ;
Braibant, Martine .
JOURNAL OF VIROLOGY, 2019, 93 (06)
[10]   Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic [J].
Bouvin-Pley, Melanie ;
Morgand, Marion ;
Moreau, Alain ;
Jestin, Pauline ;
Simonnet, Claire ;
Tran, Laurent ;
Goujard, Cecile ;
Meyer, Laurence ;
Barin, Francis ;
Braibant, Martine .
PLOS PATHOGENS, 2013, 9 (07)